| dc.identifier.citation | Berg, S., Bergh, M., Hellberg, S., Högdin, K., Lo-Alfredsson, Y., Söderman, P., von Berg, S., Weigelt, T., Ormö, M., Xue, Y., Tucker, J., Neelissen, J., Jerning, E., Nilsson, Y. and Bhat, R. (2012) 'Discovery of Novel Potent and Highly Selective Glycogen Synthase Kinase-3β (GSK3β) Inhibitors for Alzheimer’s Disease: Design, Synthesis, and Characterization of Pyrazines', Journal of Medicinal Chemistry, 55(21), pp. 9107-9119. Bertrand, J. A., Thieffine, S., Vulpetti, A., Cristiani, C., Valsasina, B., Knapp, S., Kalisz, H. M. and Flocco, M. (2003) 'Structural Characterization of the GSK-3β Active Site Using Selective and Non-selective ATP- mimetic Inhibitors', Journal of Molecular Biology, 333(2), pp. 393- 407. Bhat, R., Xue, Y., Berg, S., Hellberg, S., Ormö, M., Nilsson, Y., Radesäter, A.-C., Jerning, E., Markgren, P.-O., Borgegård, T., Nylöf, M., Giménez- Cassina, A., Hernández, F., Lucas, J. J., Díaz-Nido, J. and Avila, J. (2003) 'Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418', Journal of Biological Chemistry, 278(46), pp. 45937-45945. Cohen, P. and Goedert, M. (2004) 'GSK3 inhibitors: development and therapeutic potential', Nat Rev Drug Discov, 3(6), pp. 479-487. Gentile, G., Bernasconi, G., Pozzan, A., Merlo, G., Marzorati, P., Bamborough, P., Bax, B., Bridges, A., Brough, C., Carter, P., Cutler, G., Neu, M. and Takada, M. (2011) 'Identification of 2-(4- pyridyl)thienopyridinones as GSK- 3β inhibitors', Bioorganic & Medicinal Chemistry Letters, 21(16), pp. 4823-4827. Gentile, G., Merlo, G., Pozzan, A., Bernasconi, G., Bax, B., Bamborough, P., Bridges, A., Carter, P., Neu, M., Yao, G., Brough, C., Cutler, G., Coffin, A. and Belyanskaya, S. (2012) '5-Aryl-4- carboxamide-1,3-oxazoles: Potent and selective GSK-3 inhibitors', Bioorganic & Medicinal Chemistry Letters, 22(5), pp. 1989-1994. Meijer, L., Flajolet, M. and Greengard, P. (2004) 'Pharmacological inhibitors of glycogen synthase kinase 3', Trends in pharmacological sciences, 25(9), pp. 471-480. Meijer, L., Skaltsounis, A.-L., Magiatis, P., Polychronopoulos, P., Knockaert, M., Leost, M., Ryan, X. P., Vonica, C. A., Brivanlou, A., Dajani, R., Crovace, C., Tarricone, C., Musacchio, A., Roe, S. M., Pearl, L. and Greengard, P. (2003) 'GSK-3- Selective Inhibitors Derived from Tyrian Purple Indirubins', Chemistry & Biology, 10(12), pp. 1255-1266. Menichincheri, M., Bargiotti, A., Berthelsen, J., Bertrand, J. A., Bossi, R., Ciavolella, A., Cirla, A., Cristiani, C., Croci, V., D’Alessio, R., Fasolini, M., Fiorentini, F., Forte, B., Isacchi, A., Martina, K., Molinari, A., Montagnoli, A., Orsini, P., Orzi, F., Pesenti, E., Pezzetta, D., Pillan, A., Poggesi, I., Roletto, F., Scolaro, A., Tatò, M., Tibolla, M., Valsasina, B., Varasi, M., Volpi, D., Santocanale, C. and Vanotti, E. (2009) 'First Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potent and Orally Active Antitumor Agents. 2. Lead Discovery', Journal of Medicinal Chemistry, 52(2), pp. 293- 307. Saitoh, M., Kunitomo, J., Kimura, E., Iwashita, H., Uno, Y., Onishi, T., Uchiyama, N., Kawamoto, T., Tanaka, T., Mol, C. D., Dougan, D. R., Textor, G. P., Snell, G. P., Takizawa, M., Itoh, F. and Kori, M. (2009) '2-{3-[4- (Alkylsulfinyl)phenyl]-1-benzofuran- 5-yl}-5-methyl-1,3,4-oxadiazole Derivatives as Novel Inhibitors of Glycogen Synthase Kinase-3β with Good Brain Permeability', Journal of Medicinal Chemistry, 52(20), pp. 6270-6286. Salentin, S., Schreiber, S., Haupt, V. J., Adasme, M. F. and Schroeder, M. (2015) 'PLIP: fully automated protein–ligand interaction profiler', Nucleic Acids Research, 43(W1), pp. W443-W447. Sivaprakasam, P., Han, X., Civiello, R. L., Jacutin-Porte, S., Kish, K., Pokross, M., Lewis, H. A., Ahmed, N., Szapiel, N., Newitt, J. A., Baldwin, E. T., Xiao, H., Krause, C. M., Park, H., Nophsker, M., Lippy, J. S., Burton, C. R., Langley, D. R., Macor, J. E. and Dubowchik, G. M. (2015) 'Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in- depth exploration of chemical space around a pyrrolopyridinone core', Bioorganic & Medicinal Chemistry Letters, 25(9), pp. 1856-1863. | in_ID |
